Episode

The SPRAVATO® Story with Dr. Hussesini K. Manji,

Podcast: Psychiatry Tomorrow
Published: Oct 24, 2024
Duration seconds: 1432
Processing state: not_requested
Canonical source: https://psychiatry-tomorrow.simplecast.com/episodes/the-spravato-story-with-dr-hussesini-manji-wbRmm_6p
Audio: https://cdn.simplecast.com/audio/7c4e7234-fd4f-46db-ab02-6c8ac13c0a6a/episodes/295dc222-b29e-4c99-865b-90c07788369f/audio/0dcb3767-ae10-4fb0-96fe-ffe73e985187/default_tc.mp3?aid=rss_feed&feed=oh4b3Jfb
JSON: /v1/public/podcasts/psychiatry-tomorrow-6379352/episodes/the-spravato-story-with-dr-hussesini-k-manji
Markdown: /podcast/psychiatry-tomorrow-6379352/the-spravato-story-with-dr-hussesini-k-manji.md

Actions

POST https://stenobird.com/v1/public/podcasts/psychiatry-tomorrow-6379352/episodes/the-spravato-story-with-dr-hussesini-k-manji/transcription-requests
Idempotently request low-priority transcript generation for this episode.
GET https://stenobird.com/podcast/psychiatry-tomorrow-6379352/the-spravato-story-with-dr-hussesini-k-manji.md
Read the agent-friendly Markdown representation of this episode resource.

Summary

Dr. Husseini K. Manji reveals the groundbreaking journey of esketamine (SPRAVATO®) from lab to FDA approval. Discover how this rapid-acting antidepressant is reshaping depression treatment and paving the way for future psychedelic medicines.